Checkpoint blockade therapy resistance in Hodgkin's lymphoma

被引：4
|
作者：
Carbone, Antonin [1 ]
Gloghini, Annunziata [2 ]
机构：
[1] Ist Ricovero & Cura Carattere Sci, Ctr Riferimento Oncol Aviano, Dept Pathol, I-33081 Aviano, Italy
[2] Ist Nazl Tumori Milano, Fdn Ist Ricovero & Cura Carattere Sci, Dept Diagnost Pathol & Lab Med, Milan, Italy
来源：
LANCET | 2018年 / 392卷 / 10154期
关键词：
CELLS;
D O I：
10.1016/S0140-6736(18)31867-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1194 / 1196
页数：4
相关论文
共 50 条
  • [1] Checkpoint blockade in Hodgkin and non-Hodgkin lymphoma
    Merryman, Reid W.
    Armand, Philippe
    Wright, Kyle T.
    Rodig, Scott J.
    BLOOD ADVANCES, 2017, 1 (26) : 2643 - 2654
  • [2] Is it time to rethink checkpoint blockade therapy in non-Hodgkin lymphoma?
    Phillips, Elizabeth H.
    Illidge, Tim M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 191 (01) : 13 - 14
  • [3] Checkpoint Blockade Treatment May Sensitize Hodgkin Lymphoma to Subsequent Therapy
    Carreau, Nicole A.
    Pail, Orrin
    Armand, Philippe
    Merryman, Reid
    Advani, Ranjana H.
    Spinner, Michael A.
    Herrera, Alex
    Chen, Robert
    Tomassetti, Sarah
    Ramchandren, Radhakrishnan
    Hamid, Muhammad S.
    Assouline, Sarit
    Santiago, Raoul
    Wagner-Johnston, Nina
    Paul, Suman
    Svoboda, Jakub
    Bair, Steven
    Barta, Stefan
    Liu, Yang
    Nathan, Sunita
    Karmali, Reem
    Burkart, Madelyn
    Torka, Pallawi
    David, Kevin
    Wei, Catherine
    Lansigan, Frederick
    Emery, Lukas
    Persky, Daniel
    Smith, Sonali
    Godfrey, James
    Chavez, Julio
    Xia, Yuhe
    Troxel, Andrea B.
    Diefenbach, Catherine
    ONCOLOGIST, 2020, 25 (10): : 878 - 885
  • [4] Immune Checkpoint Blockade for the Treatment of Hodgkin Lymphoma
    Lin, Adam Yuh
    Schnitter, Joseph Michael
    Gordon, Leo, I
    IMMUNOTARGETS AND THERAPY, 2022, 11 : 1 - 10
  • [5] Checkpoint blockade therapy in Hodgkin lymphoma: improved response through combination with JAK inhibition
    Weniger, Marc A.
    Kueppers, Ralf
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
  • [6] Update on checkpoint blockade therapy for lymphoma
    Kline, Justin
    Bishop, Michael R.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2015, 3
  • [7] Synchronizing the use of allogeneic hematopoietic cell transplantation in checkpoint blockade therapy for Hodgkin lymphoma
    Mussetti, Alberto
    Vilaseca, Anna Bosch
    Parody, Rocio
    Paviglianiti, Annalisa
    Domingo-Domenech, Eva
    Sureda, Ana Maria
    EXPERT REVIEW OF HEMATOLOGY, 2021, 14 (09) : 809 - 818
  • [8] Tumor microenvironment contribution to checkpoint blockade therapy: lessons learned from Hodgkin lymphoma
    Carbone, Antonino
    Gloghini, Annunziata
    Carlo-Stella, Carmelo
    BLOOD, 2023, 141 (18) : 2187 - 2193
  • [9] Checkpoint Blockade Therapy May Sensitize Aggressive and Indolent Non-Hodgkin Lymphoma to Subsequent Therapy
    Carreau, Nicole A.
    Pail, Orrin
    Armand, Philippe
    Merryman, Reid W.
    Advani, Ranjana H.
    Spinner, Michael A.
    Herrera, Alex F.
    Chen, Robert W.
    Tomassetti, Sarah
    Ramchandren, Radhakrishnan
    Hamid, Muhammad
    Assouline, Sarit
    Santiago, Raoul
    Wagner-Johnston, Nina D.
    Paul, Suman
    Svoboda, Jakub
    Bair, Steven M.
    Barta, Stefan Klaus
    Liu, Yang
    Nathan, Sunita
    Burkart, Madelyn
    Karmali, Reem
    Torka, Pallawi
    David, Kevin A.
    Wei, Catherine
    Lansigan, Frederick
    Emery, Lukas
    Persky, Daniel
    Smith, Sonali M.
    Chavez, Julio C.
    Xia, Yuhe
    Troxel, Andrea B.
    Diefenbach, Catherine
    BLOOD, 2018, 132
  • [10] Checkpoint inhibitors in Hodgkin's lymphoma
    Novakovic, Barbara Jezersek
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 96 (04) : 335 - 343
12345